These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7489324)

  • 1. Corticotropin-releasing factor microinfused into the locus coeruleus produces electrocortical desynchronization and immunosuppression.
    Nisticò G; Caroleo MC; Arbitrio M; Pulvirenti L
    Neuroimmunomodulation; 1994; 1(2):135-40. PubMed ID: 7489324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocortical power spectrum changes induced by microinfusion of corticotropin-releasing factor into the locus coeruleus in rats.
    De Sarro GB; Fratta W; Giglio A; Nisticò G
    Funct Neurol; 1992; 7(5):407-12. PubMed ID: 1292962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that CRH microinfused into the locus coeruleus decreases cell-mediated immune response in rats.
    Caroleo MC; Pulvirenti L; Arbitrio M; Lopilato R; Nisticò G
    Funct Neurol; 1993; 8(4):271-7. PubMed ID: 8314119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity.
    Curtis AL; Lechner SM; Pavcovich LA; Valentino RJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):163-72. PubMed ID: 9103494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus.
    Page ME; Abercrombie ED
    Synapse; 1999 Sep; 33(4):304-13. PubMed ID: 10421711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinfusion of corticotropin-releasing factor into the locus coeruleus/subcoeruleus nuclei inhibits gastric acid secretion via spinal pathways in the rat.
    Mönnikes H; Tebbe J; Bauer C; Lauer G; Arnold R
    Brain Res; 1996 Jul; 728(2):157-65. PubMed ID: 8864477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress.
    Curtis AL; Pavcovich LA; Valentino RJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1211-9. PubMed ID: 10336508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
    Curtis AL; Grigoriadis DE; Page ME; Rivier J; Valentino RJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):359-65. PubMed ID: 8301577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRF(1) receptor antagonist, NBI-35965, abolished the activation of locus coeruleus neurons induced by colorectal distension and intracisternal CRF in rats.
    Kosoyan HP; Grigoriadis DE; Taché Y
    Brain Res; 2005 Sep; 1056(1):85-96. PubMed ID: 16095571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the locus coeruleus in corticotropin-releasing hormone and stress-induced suppression of pulsatile luteinizing hormone secretion in the female rat.
    Mitchell JC; Li XF; Breen L; Thalabard JC; O'Byrne KT
    Endocrinology; 2005 Jan; 146(1):323-31. PubMed ID: 15486230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus.
    Butler PD; Weiss JM; Stout JC; Nemeroff CB
    J Neurosci; 1990 Jan; 10(1):176-83. PubMed ID: 2299391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex.
    Smagin GN; Swiergiel AH; Dunn AJ
    Brain Res Bull; 1995; 36(1):71-6. PubMed ID: 7882052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility.
    Snyder K; Wang WW; Han R; McFadden K; Valentino RJ
    Neuropsychopharmacology; 2012 Jan; 37(2):520-30. PubMed ID: 21993205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pretreatment with corticotropin-releasing factor on the electrophysiological responsivity of the locus coeruleus to subsequent corticotropin-releasing factor challenge.
    Conti LH; Foote SL
    Neuroscience; 1995 Nov; 69(1):209-19. PubMed ID: 8637619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats.
    Smagin GN; Harris RB; Ryan DH
    Neurosci Lett; 1996 Dec; 220(3):167-70. PubMed ID: 8994219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of infusion of corticotropin-releasing factor antagonist into the locus coeruleus on freezing behavior and brain catecholamines in rats.
    Swiergiel AH
    Acta Neurobiol Exp (Wars); 2003; 63(1):9-16. PubMed ID: 12784927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microinfusion of clonidine and yohimbine into locus coeruleus alters EEG power spectrum: effects of aging and reversal by phosphatidylserine.
    de Sarro GB; Bagetta G; Ascioti C; Libri V; Nisticò G
    Br J Pharmacol; 1988 Dec; 95(4):1278-86. PubMed ID: 2851361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1 beta mediates stress-induced immunosuppression via corticotropin-releasing factor.
    Saperstein A; Brand H; Audhya T; Nabriski D; Hutchinson B; Rosenzweig S; Hollander CS
    Endocrinology; 1992 Jan; 130(1):152-8. PubMed ID: 1309324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central corticotropin-releasing factor suppresses natural killer cytotoxicity.
    Irwin MR; Vale W; Britton KT
    Brain Behav Immun; 1987 Mar; 1(1):81-7. PubMed ID: 3502536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of locus coeruleus neuronal activity by interleukin-1 and the involvement of endogenous corticotropin-releasing hormone.
    Borsody MK; Weiss JM
    Neuroimmunomodulation; 2002-2003; 10(2):101-21. PubMed ID: 12372984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.